User profiles for M.D. Taylor

Michael Taylor

- Verified email at bcm.edu - Cited by 67066

Michael D. Taylor, MD, PhD

- Verified email at austin.utexas.edu - Cited by 8324

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes

DE Leisman, L Ronner, R Pinotti, MD Taylor… - The Lancet …, 2020 - thelancet.com
The description of a so-called cytokine storm in patients with COVID-19 has prompted
consideration of anti-cytokine therapies, particularly interleukin-6 antagonists. However, direct …

Helminth parasites–masters of regulation

…, N Gomez‐Escobar, M Nair, MD Taylor… - Immunological …, 2004 - Wiley Online Library
… between Treg activity in mouse model systems and the observations in human helminth
infections led us to investigate the role of Tregs in experimental nematode infections (Taylor M, …

Medulloblastomics: the end of the beginning

…, A Korshunov, P Lichter, MD Taylor… - Nature Reviews …, 2012 - nature.com
The division of medulloblastoma into different subgroups by microarray expression profiling
has dramatically changed our perspective of this malignant childhood brain tumour. Now, …

DNA methylation-based classification of central nervous system tumours

…, W Paulus, A Gajjar, GW Robinson, MD Taylor… - Nature, 2018 - nature.com
Accurate pathological diagnosis is crucial for optimal management of patients with cancer.
For the approximately 100 known tumour types of the central nervous system, standardization …

Molecular subgroups of medulloblastoma: the current consensus

MD Taylor, PA Northcott, A Korshunov, M Remke… - Acta …, 2012 - Springer
Medulloblastoma, a small blue cell malignancy of the cerebellum, is a major cause of morbidity
and mortality in pediatric oncology. Current mechanisms for clinical prognostication and …

[HTML][HTML] Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma

…, A Klekner, L Bognar, S Morrissy, F Cavalli, MD Taylor… - Cancer cell, 2012 - cell.com
Glioblastoma (GBM) is a brain tumor that carries a dismal prognosis and displays considerable
heterogeneity. We have recently identified recurrent H3F3A mutations affecting two …

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

…, WD Brown, JE Holden, R Pyzalski, MD Taylor… - Science, 2000 - science.org
Lentiviral delivery of glial cell line–derived neurotrophic factor (lenti-GDNF) was tested for
its trophic effects upon degenerating nigrostriatal neurons in nonhuman primate models of …

[HTML][HTML] Medulloblastoma comprises four distinct molecular variants

…, P French, JT Rutka, S Pfister, MD Taylor - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Purpose Recent genomic approaches have suggested the existence of multiple distinct
subtypes of medulloblastoma. We studied a large cohort of medulloblastomas to determine how …

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 …

…, RJ Gilbertson, SL Pomeroy, MD Taylor… - Acta …, 2012 - Springer
Medulloblastoma is the most common malignant brain tumor in childhood. Molecular studies
from several groups around the world demonstrated that medulloblastoma is not one …

Mutations in SUFU predispose to medulloblastoma

MD Taylor, L Liu, C Raffel, C Hui, TG Mainprize… - Nature …, 2002 - nature.com
The sonic hedgehog (SHH) signaling pathway directs the embryonic development of diverse
organisms and is disrupted in a variety of malignancies. Pathway activation is triggered by …